Live Breaking News & Updates on Hedge Funds Weigh In On Merrimack Pharmaceuticals

Stay updated with breaking news from Hedge funds weigh in on merrimack pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merrimack Pharmaceuticals (NASDAQ:MACK) Cut to "Sell" at StockNews.com

StockNews.com cut shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. Merrimack Pharmaceuticals Trading Up 0.1 % Merrimack Pharmaceuticals stock opened at $15.13 on Monday. The firm has a market capitalization of $219.84 million, a P/E ratio of -189.13 and […] ....

United States , United Kingdom , Wittenberg Investment Management Inc , Kennedy Capital Management , Merrimack Pharmaceuticals Trading , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Aristides Capital , Merrimack Pharmaceuticals Increases Dividend , Merrimack Pharmaceuticals , News Ratings For Merrimack Pharmaceuticals Daily , Free Report , Get Free Report , Financial Markets , Capital Management , Investment Management , Merrimack Pharmaceuticals Daily ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Shares Cross Above 200-Day Moving Average of $12.40

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $12.40 and traded as high as $13.39. Merrimack Pharmaceuticals shares last traded at $13.32, with a volume of 36,749 shares. Analyst Ratings Changes Separately, StockNews.com upgraded shares […] ....

United States , United Kingdom , Eric Andersen , Merrimack Pharmaceuticals Inc , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Citigroup Inc , American International Group Inc , Wittenberg Investment Management Inc , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Stock Performance , Get Free Report , Director Eric Andersen , International Group , Investment Management , State Teachers Retirement System , Merrimack Pharmaceuticals Daily , Nasdaq Mack ,

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Director Acquires $1,298,492.50 in Stock

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) Director Eric Andersen bought 101,050 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The stock was bought at an average cost of $12.85 per share, for a total transaction of $1,298,492.50. Following the completion of the transaction, the director now directly […] ....

United States , United Kingdom , Eric Andersen , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals , Quarter For Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Wittenberg Investment Management Inc , Merrimack Pharmaceuticals Trading , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Kennedy Capital Management , Get Free Report , Director Eric Andersen , Capital Management , Investment Management , Sepio Capital , Merrimack Pharmaceuticals Daily , Nasdaq Mack , Insider Trading , Nsider Trades ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Passes Above 200 Day Moving Average of $12.28

Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Passes Above 200 Day Moving Average of $12.28
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Merrimack Pharmaceuticals Stock , Wells Fargo Company , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Company Profile , Merrimack Pharmaceuticals Inc , Citigroup Inc , News Ratings For Merrimack Pharmaceuticals Daily , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Get Free Report , State Teachers Retirement System , Wells Fargo , Merrimack Pharmaceuticals Daily ,

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Update

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Garyl Crocker , Eric Andersen , Merrimack Pharmaceuticals Trading Down , Wells Fargo Company , Kennedy Capital Management , Merrimack Pharmaceuticals Inc , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals Company Profile , Tower Research Capital , Merrimack Pharmaceuticals , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Get Free Report , Director Eric Andersen , State Teachers Retirement System , Capital Management , Research Capital , State Street Corp , Street Corp , Pharmaceuticals Trading Down , Merrimack Pharmaceuticals Daily ,